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Summary
In cerebral cortex there is a developmental switch from NR2B- to NR2A-containing NMDA
receptors (NMDARs) driven by activity and sensory experience. This subunit switch alters
NMDAR function, influences synaptic plasticity, and its dysregulation is associated with
neurological disorders. However, the mechanisms driving the subunit switch are not known. Here
we show in hippocampal CA1 pyramidal neurons that the NR2B- to NR2A switch driven acutely
by activity requires activation of NMDARs and mGluR5, involves PLC, Ca2+ release from IP3R-
dependent stores and PKC activity. In mGluR5 knock-out mice the developmental NR2B-NR2A
switch in CA1 is deficient. Moreover, in visual cortex of mGluR5 knock-out mice the NR2B-
NR2A switch evoked in vivo by visual experience is absent. Thus we establish that mGluR5 and
NMDARs are required for the activity-dependent NR2B-NR2A switch and play a critical role in
experience-dependent regulation of NMDAR subunit composition in vivo.
INTRODUCTION
The NMDA receptor (NMDAR) is a ligand-gated ion channel permeable to Na+, K+ and
Ca2+, and is found at excitatory synapses throughout the brain. NMDARs are required for
many forms of learning and memory, and are implicated in numerous neurological disorders
(Cull-Candy et al., 2001). Glutamate is the major excitatory neurotransmitter in the brain; it
serves as the ligand for NMDARs and receptor activation requires glutamate binding and
membrane depolarization. Such coincidence detection and calcium permeability enables the
NMDAR to play a pivotal role in synaptic function and plasticity (Bliss and Collingridge,
1993). NMDARs are heterotetramers composed of two NR1 subunits and two NR2 subunits.
Most of the diversity in the single channel and pharmacological properties of NMDARs
arises from the NR2 subunit composition of the receptor (Cull-Candy et al., 2001).
NMDAR subunit composition varies between different brain regions and throughout
development (Monyer et al., 1994; Cull-Candy et al., 2001) In cerebral cortex there is a
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ubiquitous regulation of NR2 subunit composition during development in which NR2B is
the major NR2 subunit during the first postnatal week with NR2A expression increasing
thereafter (Monyer et al., 1994; Sans et al., 2000; Sheng et al., 1994). NR2B-containing
NMDARs exhibit slower kinetics than NR2A-containing receptors (Williams et al., 1993)
and are also selectively blocked by ifenprodil and related compounds (Williams, 1993).
Consistent with the expression changes in NR2 subunits, NMDAR currents at cortical
synapses exhibit faster decay kinetics and reduced sensitivity to ifenprodil during
development (Carmignoto and Vicini, 1992; Hestrin, 1992; Flint et al., 1997; Tovar and
Westbrook, 1999; Kirson and Yaari, 1996; Williams et al., 1993) demonstrating that
synaptic NMDARs switch from those predominantly containing NR2B to those containing
NR2A. The switch in NR2 subunit composition is dependent on neuronal activity and
experience. In primary visual cortex the developmental switch requires visual experience
(Carmignoto and Vicini, 1992) and in dark-reared animals can be rapidly induced with only
1 hour of exposure to visual experience (Quinlan et al., 1999; Philpot et al., 2001).
Moreover, at synapses on hippocampal CA1 pyramidal neurons synaptic activity can drive
NR2A subunits into synapses (Barria and Malinow 2002) and LTP induction in the neonate
acutely drives the switch of synaptic NMDARs from NR2B- to NR2A-containing (Bellone
and Nicoll, 2007). The NR2B to NR2A switch causes important changes to NMDAR
function, altering the amount of calcium influx through the pore and the types of proteins
interacting with the intracellular domain of the receptor. These features regulate the type of
long-term synaptic plasticity (LTP or LTD) that NMDAR activation can induce, although
the exact relationship between NR2 subunits and the induction of LTP and LTD remains
controversial (Bartlett et al., 2007; Liu et al., 2004; Morishita et al., 2007; Xu et al., 2009).
Despite the ubiquitous nature and critical roles of the NR2B-NR2A switch in cortical
synapse function and plasticity during development, the mechanisms for induction of the
subunit switch has not been characterized. We now show that the acute activity-dependent
subunit switch induced by an LTP induction protocol in hippocampal CA1 pyramidal cells
requires activation of both NMDARs and mGluR5. Further we find that a signaling cascade
involving PLC activation, release of calcium from IP3R-dependent stores and PKC activity
is required. However, unlike LTP-induced changes in AMPAR function, the activity-
dependent switch in NR2 subunit composition does not require CaMKII or PKA activity.
Using mGluR5 knock-out mice, we confirm the requirement for mGluR5 in acutely driving
the switch in CA1 hippocampus. Further, we show that the mGluR5 knock-out mice have a
deficient developmental switch from NR2B- to NR2A-containing receptors at synapses onto
hippocampal CA1 pyramidal neurons and onto layer 2/3 pyramidal primary visual cortical
neurons. Moreover, the experience-dependent switch from NR2B to NR2A-containing
receptors in layer 2/3 visual cortex of dark-reared animals induced by brief (2.5 hours) light
exposure is absent in mGluR5 knock-out mice. Thus we define the mechanisms for the
activity-dependent switch in NR2 subunit composition at CA1 synapses and further
demonstrate a crucial role in vivo for mGluR5 in driving the experience-dependent switch in
NR2 subunit composition.
RESULTS
Activity-dependent change in the NMDAR NR2 subunit composition at hippocampal CA1
pyramidal cell synapses
During the first week of postnatal development, most NMDARs at cortical synapses contain
NR2B, whereas by the third postnatal week, a change in composition has occurred whereby
the majority of receptors now contain NR2A and lack NR2B (Monyer et al., 1994; Sans et
al., 2000; Sheng et al., 1994). Previous work shows that a pairing protocol, which induces
LTP of AMPAR-mediated synaptic transmission, also causes a switch of NMDAR subunit
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composition from NR2B- to NR2A-containing at CA1 synapses in acute hippocampal slices
prepared from postnatal day (P)2 - P9 rats (Bellone and Nicoll, 2007). We used this
paradigm to investigate the mechanism for the activity-dependent switch in NR2 subunit
composition. Using whole-cell patch-clamp recordings from CA1 pyramidal neurons in
acute hippocampal slices, we monitored pharmacologically isolated NMDAR-mediated
EPSCs (voltage-clamped at a holding potential of +40 mV to relieve voltage-dependent
magnesium block on the NMDAR, in the presence of 5 μM NBQX and 50 μM picrotoxin)
evoked at two independent Schaffer collateral/commissural inputs. Following a baseline
period we applied a pairing protocol (1 Hz afferent stimulation for 120 seconds at a holding
potential of 0 mV) to one pathway (test path). This induction protocol did not cause a
change in NMDA EPSC peak amplitude; however, it did produce a speeding of NMDA
EPSC decay in the test path, whereas the control path did not exhibit any change in kinetics
(Fig. 1A, B). On average, the weighted time constant (τw) for the EPSC decay in the test
path was ~ 71 ms faster after the induction protocol compared to before the induction
protocol, whereas there was no significant difference in the control path (Fig. 1D). In the
same cells we then bath-applied the NR2B selective inhibitor, ifenprodil (5 μM) and found
that the NMDA EPSCs in the test path were blocked to a smaller degree than those in the
control path (Fig. 1A, C). Across all cells, in the control path, ifenprodil reduced the
NMDAR EPSC amplitude to ~ 41% of pre-ifenprodil baseline (immediately prior to
ifenprodil application), whereas in the test path, ifenprodil was much less effective, only
reducing EPSCs to ~ 76 % of pre-drug amplitude (Fig. 1E). These results confirm previous
findings (Bellone and Nicoll, 2007) that synaptic activity rapidly drives a switch in synaptic
NMDAR composition from those containing NR2B to NR2A-containing receptors.
Moreover, in these experiments application of ifenprodil caused NMDA EPSC kinetics to
become faster in the control path; however, in the test path ifenprodil did not cause a
speeding of kinetics (Fig. S1). This lack of a significant change in kinetics in the test path
after application of ifenprodil reflects the small amount of ifenprodil block at this input.
These findings confirm that ifenprodil exerts its action by selectively blocking NR2B-
containing NMDARs that mediate the slow kinetics of the EPSC and provides further
evidence that such receptors are removed from synapses during LTP.
Previous work suggests that long periods of baseline stimulation can itself induce plasticity
of the NMDAR EPSC (Bellone and Nicoll, 2007). Therefore to determine if our baseline
stimulation protocol (10 EPSCs evoked at 0.1 Hz) was inducing any plasticity we reduced
the baseline to 4 evoked responses per path and then tested whether a similar degree of
change in kinetics and ifenprodil sensitivity could be induced by the induction protocol.
Under these reduced baseline conditions, we observed a similar degree of change in the
NMDAR EPSC decay kinetics and ifenprodil sensitivity produced by the induction protocol
as for the previous data set with the longer baseline (Fig. S2). Thus our baseline stimulation
protocol itself does not evoke significant activity-dependent changes in NMDAR subunit
composition.
The interpretation that NR2B-containing NMDARs are removed from synapses and
replaced with NR2A relies on the changes in kinetics and pharmacology of the NMDAR
EPSC. However, for this latter assay, ifenoprodil may have actions at targets other than
NR2B; therefore, in a separate set of experiments we tested changes in sensitivity to a
second NR2B selective antagonist, Ro25-6981. We observed a very similar change in the
sensitivity to Ro25-6981 as for ifenprodil following induction of the NMDAR subunit
switch (Fig. S3). In addition, we developed a culture model to directly image changes in
NR2B and NR2A synaptic localization. At DIV 4, cultured hippocampal neurons were
chronically treated with D-AP5 to inhibit the developmental subunit switch. After 10 days,
D-AP5 was washed off and the cultures treated with glycine to induce an acute switch in
NR2 subunit composition. This treatment caused an increase in surface NR2A localization at
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synapses and a concomitant loss of NR2B (Fig. S4). Taken together, these findings provide
strong evidence that activity drives a rapid switch from NR2B- to NR2A-containing
receptors at synapses on CA1 pyramidal neurons.
The activity-dependent change in NMDAR NR2 subunit composition requires mGluR5 and
NMDARs
The activity-dependent switch in NR2 subunit composition is rapid and input specific (Fig.
1; Bellone and Nicoll 2007). However the mechanism for its induction is unknown. To
investigate this issue we first tested a role for glutamate receptors. As shown in figure 1, and
as reported previously (Bellone and Nicoll 2007), the subunit switch can be induced in the
presence of NBQX, excluding a requirement for AMPAR activation in the induction
mechanism. We therefore hypothesized that NMDAR and/or mGluR activation is required
since both these mechanisms cause a rise in spine free calcium concentration that is typically
required for induction of synaptic plasticity. The predominant postsynaptic mGluR subtype
at CA1 pyramidal cell synapses is mGluR5; therefore, we applied the induction protocol in
the presence of MTEP (10 μM), a selective mGluR5 antagonist (Cosford et al., 2003).
MTEP fully blocked the activity-dependent speeding of the NMDA EPSC decay kinetics
and reduction in NMDA EPSC ifenprodil sensitivity in the test pathway (Fig. 2A-C, J, K).
We also tested whether mGluR1 plays any role in the induction of the switch by testing the
effects of LY367385 (100 μM), a selective mGluR1 antagonist (Kingston et al., 1999).
However, LY367385 failed to block the activity-induced switch in kinetics or ifenprodil
sensitivity (Fig. 2D-F, J, K).
We next addressed a role for NMDARs themselves in the induction of the NR2 subunit
composition switch. NMDAR activation requires depolarization to relieve the voltage-
dependent Mg2+ block to allow current flow through the ion channel. Therefore, we first
tested a requirement for postsynaptic depolarization in induction of the NR2 subunit switch.
In cells in which the test path was stimulated at 1 Hz while the cell was clamped at −70 mV
the induction protocol failed to significantly change the NMDA EPSC decay kinetics (Fig.
2J) or ifenprodil sensitivity (Fig. 2K). In the next set of experiments to specifically address
the role of NMDARs, we blocked NMDA EPSCs with D-AP5 (50 μM). Once the blockade
was complete, we applied the induction protocol and commenced wash-out of D-AP5
immediately. After 20 minutes of wash-out when NMDA EPSCs had recovered to a stable
amplitude, decay kinetics between control and test pathways were compared and then
ifenprodil was bath-applied (Fig. 2G). D-AP5 completely prevented the activity-dependent
switch in NR2 subunit composition (Fig. 2H-K). In control experiments we also tested
whether the inability to induce the NR2 subunit switch was due to the extra 20 minutes
delay between the induction protocol and the recording of NMDAR EPSCs. We repeated the
experiment in the absence of D-AP5 and waited 20 minutes after the induction protocol
before comparing NMDAR EPSCs between the control and test paths. Under these
conditions, we still reliably observed the differences in the NMDAR EPSC decay kinetics
and ifenprodil sensitivity between the control and test paths (Fig. S5).
Previous work has shown that another form of mGluR5-dependent synaptic plasticity,
mGluR LTD, requires new protein translation for its expression (Huber et al., 2000).
Therefore, we tested whether the protein synthesis inhibitor cycloheximide (60 μM), applied
for 1 hour prior to and during the induction protocol, blocked the switch. In the presence of
cycloheximide the induction protocol caused robust changes in the NMDAR EPSC decay
kinetics and ifenprodil sensitivity (Fig. 2J & K). Taken together, these findings show that the
activity-dependent switch in NMDAR NR2 subunit composition requires co-activation of
mGluR5 and NMDARs for its induction, but not mGluR1 or new protein synthesis.
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PLC and calcium signaling are required for the activity-dependent switch in the NR2
subunit composition
Activation of either NMDARs or mGluR5 leads to a rise in intracellular calcium. We first
confirmed the requirement for a rise in postsynaptic free calcium concentration in the
activity-dependent NR2 subunit switch (Bellone and Nicoll 2007) by using the calcium
chelator BAPTA (10 mM) in the whole-cell recording solution. Postsynaptic BAPTA
prevented the pairing protocol-induced speeding of NMDA EPSC kinetics and reduction in
ifenprodil sensitivity (Fig. 3J, K).
Whereas a role for calcium influx through NMDARs in generating increases in postsynaptic
free calcium concentration is well established, the role for mGluR5-dependent calcium
signaling at spines is not so well characterized. To investigate this issue we used two-photon
laser scanning microscopy and calcium imaging of spines in CA1 pyramidal neurons in
neonatal hippocampal slices. Pyramidal neurons were co-loaded with a calcium-insensitive
dye (Alexa 594) and the calcium-sensitive dye Fluo-5F via a patch electrode. A stimulating
electrode placed local to the dendrite of interest was used to evoke minimal EPSCs and a
spine was identified that responded with a calcium elevation (Fig. S6A-B). A paired pulse
stimulation protocol was employed to more reliably elicit synaptic responses because failure
rates are high in response to single shock stimulation when using a minimal stimulation
protocol. We then compared the spine calcium transient evoked during baseline and in the
presence of MTEP and found that MTEP caused a ~50 % reduction in the spine calcium
response (Fig. S6C-E). Thus in these neonatal CA1 pyramidal neurons mGluR5 signaling
mediates a significant fraction of the evoked postsynaptic calcium transient.
Glutamate binding to mGluR5 leads to activation of PLC and release of calcium from
intracellular stores. To test a possible role for this downstream signaling pathway in driving
the NR2 subunit switch, we first investigated whether U73122 (5 μM), an inhibitor of PLC,
blocked the induction of the subunit switch. In the presence of bath-applied U73122 the
induction protocol failed to cause a speeding of NMDA EPSC decay kinetics or reduction
ifenprodil sensitivity (Fig. 3A-C, J, K).
We next tested whether calcium release from intracellular stores is involved in the subunit
switch. In a first set of experiments we bath-applied thapsigargin (5 μM), which blocks the
SERCA pump and causes a rapid depletion of intracellular calcium stores in neurons. In the
presence of thapsigargin the changes in EPSC kinetics and ifenprodil sensitivity were
completely blocked (Fig. 3J, K). Since PLC activation leads to synthesis of IP3, we tested a
role for release of calcium from IP3 sensitive stores using two IP3 receptor inhibitors,
heparin and 2APB. We included heparin (10 mg/mL) in the intracellular solution and in a
separate set of experiments we bath-applied 2APB (100 μM), which is membrane-
permeable. In both sets of experiments the induction protocol failed to cause a change in
NMDA EPSC kinetics or ifenprodil sensitivity (Fig. 3J, K). PLC activity also leads to
activation of PKC due to the synthesis of DAG and the rise in free calcium concentration
that potentially activates a number of PKC isoforms. Therefore we also tested whether PKC
activity is required for the NR2 subunit switch and found that application of the induction
protocol in the presence of bath-applied GF109203X (1 μM), a PKC inhibitor, prevented the
speeding of the NMDA EPSC kinetics and the change in ifenprodil sensitivity (Fig. 3D-F, J,
K). Finally, we also tested a role for PKA and CaMKII, two other kinases known to be
involved in synaptic plasticity at CA1 synapses (Malenka and Nicoll, 1999). However,
neither inhibition of PKA with H89 (10 μM), nor inhibition of CaMKII with KN93 (10 μM)
prevented the activity-dependent change in decay kinetics or ifenprodil sensitivity (Fig. 3G-
K). Taken together, these findings show that the activity-dependent switch in NR2 subunit
composition requires PLC activity (but not CaMKII or PKA activity), calcium release from
postsynaptic IP3R-dependent intracellular stores and PKC activation.
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The activity-dependent and developmental switch in NR2 subunit composition at CA1
synapses is impaired in mGluR5 knock-out mice
Our approach using multiple chemically-unrelated inhibitors to probe numerous steps in the
same signaling pathway make it very unlikely that the results we obtain can be explained by
off-target effects of the reagents. However, we also used a genetic approach using mGluR5
knock-out mice both to confirm the role for mGluR5 in the activity-dependent NR2 subunit
switch and also to study the role of mGluR5 in NMDAR regulation in vivo. However, when
we used the pairing protocol as for the rat slice experiments in hippocampal slices from P5-
P7 wild type mice, we could not evoke any robust change in NMDA EPSC kinetics or
ifenprodil sensitivity (not shown). One possibility is that the ability to induce the activity-
dependent switch ‘washes out’ rapidly in mouse CA1 pyramidal neurons during whole-cell
recordings, similar to the wash-out of AMPAR LTP commonly observed in CA1 pyramidal
neurons (Malinow and Tsien, 1990). Recent work shows that high frequency stimulation
(100 Hz for 6 s) can change ifenprodil sensitivity of NMDAR-mediated transmission at
hippocampal CA1 synapses in adolescent rats (Xu et al., 2009). Therefore we tested whether
this induction protocol applied to the test pathway prior to obtaining a whole cell recording
could induce the NR2 subunit switch in slices from P5-P7 mice. Application of this high
frequency stimulation protocol to the test pathway 20-30 minutes prior to commencing
whole-cell recording, consistently caused a speeding in the decay of NMDAR EPSCs in the
test path and a reduction in ifenprodil sensitivity compared to the control path (Fig. 4A-C, J,
K). We next tested whether the activity-dependent switch induction mechanism in mouse
shares a similar signaling pathway with rat. The NR2B to NR2A switch was blocked by
MTEP, U73122, or AP5 (Fig. 4D-K) demonstrating that, like rat, the induction depends on
NMDARs, mGluR5 and PLC activation. Moreover, we also tested the mouse induction
protocol in rat hippocampal slices and found that it also robustly evoked changes in
NMDAR EPSC kinetics and ifenprodil (Fig. S7).
Next we examined whether the activity-dependent NR2 subunit switch was deficient in
mGluR5 knock-out mice. We compared slices from knock-out and heterozygous littermates
with the experimenter blind to genotype. In hippocampal slices from heterozygotes the high
frequency induction protocol caused a similar speeding of NMDA EPSC decay kinetics and
reduction in ifenprodil sensitivity, similar to that observed in wild types (Fig. 5A-C, G, H).
However, in slices from the mGluR5 knock-outs, although small variable changes in NMDA
EPSC decay and ifenprodil sensitivity occurred in some experiments following the induction
protocol, no significant change in either of these parameters was observed (Fig. 5D-H).
If the activity-dependent switch underlies the developmental regulation of NR2B/NR2A in
vivo, a prediction is that the mGluR5 knock-out mice should have altered regulation of NR2
subunit composition in vivo during development. We investigated this possibility by
comparing kinetics and ifenprodil sensitivity of NMDA EPSCs in mGluR5 knock-out mice
and wild type littermates. At P15-18, NMDA EPSCs from CA1 pyramidal cells in wild type
exhibited faster kinetics and a less sensitivity to ifenprodil compared to knock-outs (Fig. 6A-
D). However, in the knock-outs there was still a considerable speeding in NMDA EPSC
kinetics and reduction in ifenprodil sensitivity during development). Therefore, these
findings show there is a deficit in the developmental switch from NR2B- to NR2A-
containing NMDARs in the mGluR5 knock-out demonstrating a role for mGluR5 in this
process. However, our data also show that additional mechanisms can at least partly support
the developmental switch in the absence of mGluR5.
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Deficient experience-dependent NR2B-NR2A switch in visual cortex of mGluR5 knock-out
mice
The developmental switch from NR2B to NR2A-containing NMDARs is particularly
prominent in primary sensory cortex where it has been shown to depend upon sensory
experience. Particularly well studied is this process in primary visual cortex of rodents
where visual experience for as little as one hour has been shown to drive the switch from
NR2B to NR2A in dark-reared animals (Philpot et al 2001; Quinlan et al 1999), and such
regulation influences metaplasticity and is required for maturation of receptive fields (Cho et
al., 2009; Philpot et al., 2003; Philpot et al 2007). To probe the role of mGluR5 in the
regulation of NMDAR function in vivo, we tested whether the experience-dependent NR2B-
NR2A switch is deficient in primary visual cortex of mGluR5 knock-out mice.
We first determined whether there was a disruption in the developmental switch from NR2B
to NR2A in layer 2/3. We made whole-cell patch-clamp recordings from layer 2/3 pyramidal
neurons in slices of primary visual cortex and found that NMDA EPSCs elicited by layer 4
stimulation exhibited longer decay times and greater ifenprodil sensitivity in mGluR5
knock-outs compared to wild type (Fig. 6E-H). This indicates a deficiency in the
development switch from NR2B to NR2A-containing receptors.
Visual experience in dark-reared rodents causes a rapid switch from NR2B- to NR2A-
containing NMDARs at layer 4 inputs onto layer 2/3 pyramidal neurons in primary visual
cortex that depends upon NMDAR activation (Philpot et al., 2001; Quinlan et al., 1999).
Therefore we next tested whether this experience-dependent plasticity is disrupted in
mGluR5 knock-out mice. We dark-reared wild type mice and mGluR5 knock-out littermates
from P6 until P17-19, exposed some of these animals to 2.5 hours of light and then
investigated the effects on NMDA EPSCs at layer 4 inputs onto layer 2/3 pyramidal cells. In
wild-type mice NMDA EPSCs in animals exposed to light (+LE) exhibited faster kinetics
and reduced ifenprodil sensitivity compared to mice that didn’t receive light exposure (Fig
7A-E). The degree of change in these parameters was very similar to that previously
reported (Philpot et al 2001; Quinlan et al 1999) and confirms that even brief exposure to
light can drive the switch from NR2B-NR2A in visual cortex. In mGluR5 knock-out mice
light exposure failed to produce any significant change in NMDA EPSC kinetics or
ifenprodil sensitivity (Fig. 7A-E). It was also noticeable that the dark-reared wild-type and
knock-out mice (that were not exposed to light) exhibited very similar NMDA EPSC
kinetics and ifenprodil sensitivity indicating that visual experience and mGluR5 are
necessary for the developmental change from NR2B to NR2A-containing NMDARs in
visual cortex during the first few postnatal weeks.
DISCUSSION
During the first postnatal week, most cortical synapses express NR2B-containing receptors,
whereas later in development (>P14), many of these receptors are replaced with NR2A-
containing NMDARs. Synaptic activity is involved in regulating this switch, and a role for
sensory experience in primary sensory cortex has also been demonstrated; however, the
molecular mechanisms driving this ubiquitous NMDAR subtype switch have hitherto been
largely unexplored. Here, we find that activation of both mGluR5 and NMDA receptors is
required for this switch to occur at synapses on hippocampal CA1 pyramidal neurons.
Furthermore, we define a downstream signaling pathway involving PLC activation, release
of Ca2+ from IP3R-dependent stores and activation of PKC (see Fig. 8 for model). Using
mGluR5 knock-out mice we confirm the requirement for mGluR5 in the acute activity-
dependent switch at CA1 synapses. Moreover, the mGluR5 knock-outs show exhibit a
deficit in the developmental switch from NR2B to NR2A both at CA1 synapses and at
inputs onto layer 2/3 pyramidal neurons in primary visual cortex. Finally we show that the
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NR2B-NR2A switch driven by brief visual experience in layer 2/3 pyramidal neurons in
dark-reared mice is absent in the mGluR5 knock-out. These findings define the mechanism
for the activity-dependent NR2B-NR2A switch and suggest a central role for this
mechanism in the development- and experience-dependent regulation of cortical NMDAR
NR2 subunit composition.
Activity-dependent changes in NR2B and NR2A subunit composition: roles of mGluR5 and
NMDARs
Our results show that an LTP induction protocol increases the relative amount of NR2A at
CA1 synapses in an mGluR5 and NMDA receptor-dependent manner in the neonate.
Moreover, mGluR5 function plays an important role in the rapid experience-driven switch in
NR2 subunit composition in pyramidal cells in layer 2/3 of the V1 cortex. In support of a
requirement for mGluR5 and NMDARs in the activity-dependent change in the NR2
subunits, NMDARs are also required for this rapid experience-driven NR2B-NR2A switch
in primary visual cortex (Quinlan et al., 1999). Together, these findings indicate that this
mechanism may represent a ubiquitous process in the developing brain for the activity-
dependent regulation of NMDAR function. This is in addition to the variety of other
mechanisms described for the regulation of NMDAR function and trafficking in more
mature brain (for reviews see Chen and Roche, 2007; Lau and Zukin, 2007; Yashiro and
Philpot, 2008).Whether the developmental regulation of NR2 subunit composition also
involves some of the induction and expression mechanisms described in older animals is
unclear and will be of interest to study in future work. High-frequency stimulation can also
have long-lasting potentiating effects on NMDAR-mediated synaptic transmission in adult
CA1 hippocampus (Bashir et al., 1991). Interestingly, this NMDAR LTP is also dependent
on mGluR5 and NMDA receptor activation (O’Connor et al., 1994; Jia et al., 1998; Kotecha
et al., 2003; Rebola et al., 2008). Recent work shows that such NMDAR LTP also requires
membrane fusion and causes a speeding in the kinetics of the NMDA EPSC (Peng et al.,
2010). However, in the present study we did not observe significant changes in NMDAR
peak amplitudes after the induction protocol suggesting that in the neonate NR2A-
containing receptors replace NR2B-containing receptors as opposed to being added to the
existing pool of synaptic NMDARs. Consistent with NMDAR replacement in our
experiments, NR2B-containing receptors are more mobile and can diffuse to extrasynaptic
sites at greater rates than NR2A-containing receptors (Groc et al., 2006; Tovar and
Westbrook, 2002), and NMDARs more rapidly internalize early in development
(Washbourne et al., 2004; Roche et al., 2001). Ifenprodil is not an effective inhibitor of
NR1/NR2A diheteromers or NR1/NR2A/NR2B triheteromers (Hatton and Paoletti, 2005) at
the concentrations we used. Therefore, although we cannot be certain of the NMDAR
subunit composition after the induction protocol, our data strongly suggest that activity
induces a loss of NR1/NR2B diheteromers and their replacement with NR2A subunit-
containing receptors. This conclusion is further supported by the speeding of decay kinetics,
which indicates incorporation of NR2A subunit-containing receptors because this subunit
produces receptors with faster kinetics (Cull-Candy and Leszkiewicz, 2004).
Previous studies have shown that potentiation of NMDAR-mediated transmission requires
signaling downstream of mGluR5, including release of Ca2+ from IP3R-sensitive stores, and
activation of PLC and PKC (Grosshans et al., 2002; Kotecha et al., 2003; Kwon and
Castillo, 2008; Jia et al., 1998). Although the final mechanism driving the insertion of
NR2A into synapses is unclear, a recent study shows that the postsynaptic membrane
SNARE protein, SNAP-23, regulates NMDAR surface expression at synapses in
hippocampal CA1 pyramidal neurons (Suh et al., 2010). We find that the activity-dependent
switch in NR2 subunit composition requires a rise in postsynaptic calcium and release of
calcium from IP3R-dependent stores. Moreover, we find that at spines from neonates,
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mGluR5 contributes to ~ 50% of calcium transients during synaptic transmission. Thus it is
reasonable to speculate that the activity-dependent switch in the NR2 subunit requires a
certain threshold amount of calcium provided by both NMDAR and mGluR5 activation.
Consistent with a role for IP3R-dependent store release, previous work shows that at CA1
synapses activity evokes release of calcium from these stores (Ross et al., 2005).
Furthermore, there is abundant evidence for the role of PLC and calcium release from IP3R-
dependent stores in various forms of synaptic plasticity e.g. (Choi et al., 2005; Daw et al.,
2002; Fernandez de Sevilla et al., 2008; Gartner et al., 2006; Itoh et al., 2001; Taufiq et al.,
2005).
Although we have not formally tested whether all the hallmarks of the subunit switching
mechanism we describe in the slice also occur in vivo, ours and other findings strongly
suggest that this mechanism is used in vivo to drive the switch from NR2B to NR2A-
containing NMDARs. We show that the developmental switch in NR2 subunit composition
is deficient in hippocampus and visual cortex of mGluR5 knock out mice and that the
sensory experience-driven switching of NR2 subunit composition is absent in mGluR5
knock outs. Moreover, previous work also shows that in visual cortex NMDARs are
required for the experience-dependent switch in subunit composition (Quinlan et al., 1999).
Taken together these findings strongly support the idea that the mechanism we describe for
the induction of the activity-dependent switch as studied in hippocampal slices are used in
vivo to drive the NR2 subunit switch. However, the possibility remains that additional
mechanisms may also contribute in vivo and this may explain the partial switch from NR2B
to NR2A that is still observed during development in the mGluR5 knock outs.
Physiological Role
Long term changes in synaptic efficacy are typically dependent on calcium influx through
NMDARs into postsynaptic spines. The polarity of these synaptic changes (strengthening
for LTP and weakening for LTD) has been proposed to depend on the amount and temporal
dynamics of calcium influx, which could be determined by the NR2 subunit composition of
NMDARs (Malenka and Bear, 2004; Yang et al., 1999). In addition to calcium dynamics,
differences in binding of signaling molecules to the C-terminal tails of NR2A and NR2B
(Strack and Colbran, 1998; Barria and Malinow, 2005; Foster et al., 2010) may further
define the polarity of synaptic plasticity. Whether NR2B or NR2A favors LTP or LTD, and
vice versa, is still a matter of much debate (Bartlett et al., 2007; Liu et al., 2004; Morishita et
al., 2007; Xu et al., 2009). However, dysregulation of NR2 subtype expression at synapses
impairs hippocampus-dependent learning and memory demonstrating an important role for
NR2 subunits in plasticity (Sakimura et al., 1995; Sprengel et al., 1998; von Engelhardt et
al., 2008). Sensory experience shapes cortical receptive fields in primary sensory cortex
during critical periods in an NMDAR-dependent manner. In the visual cortex, a
developmental switch from NR2B- to NR2A-containing receptors coincides with this
critical period (Carmignoto and Vicini, 1992). Also, visual experience or deprivation can
rapidly increase or decrease the NR2A/2B ratio of synaptic NMDARs in a reversible manner
(Philpot et al., 2001; Quinlan et al., 1999). Similarly, whisker trimming during early
postnatal development prevents the developmental changes in the NR2 subunit in barrel
cortex (Mierau et al., 2004).
The experience-dependent switch from NR2B to NR2A has important physiological
consequences. In primary visual cortex, where this has been most well characterized, the
NR2B/NR2A ratio regulates the degree of temporal summation of NMDAR-mediated
synaptic responses, sets the modification threshold for synaptic plasticity and regulates
receptive field maturation (Cho et al., 2009; Philpot et al., 2001; Philpot et al., 2003).
Moreover, a number of neurological disorders involve dysregulation of NR2 subunits.
Increased NR2B surface expression is observed in Huntington’s Disease (Fan et al., 2007;
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Milnerwood et al.), NMDAR hypofunction and altered NR2B/NR2A trafficking is found in
mouse models of schizophrenia (Mohn et al., 1999; Tang et al., 2009), Abeta induces
internalization of NMDARs in Alzheimer’s disease models (Snyder et al., 2005), and there
is increased surface-expression of NR2A-containing NMDARs in cocaine addiction
(Borgland et al., 2006). Thus understanding the mechanisms of NR2B/NR2A regulation is
important because this can give insight into mechanisms underlying important physiological
and pathological changes in a number of brain areas and for a number of different
paradigms. Our findings now provide the characterization of the novel induction mechanism
underlying a physiological regulation of NR2 subunit composition. Our data suggest that
this mechanism is widely used in cortical neurons and it will be of great interest in future
studies to determine if this mechanism is also involved in pathological changes in NMDAR
subunit composition.
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Appendix
Experimental Procedures
Electrophysiology
4-9 day old Wistar rats were anesthetized with isoflurane and then decapitated in accordance
with NIH animal care and use guidelines. Transverse hippocampal slices (400 μm thick)
were cut in ice cold artificial cerebrospinal fluid (ACSF) containing (mM): 119 NaCl, 2.5
KCl, 2.5 CaCl2, 9 MgSO4, 1 NaH2PO4, 26.2 NaHCO3, 11 glucose equilibrated with 95% O2
and 5% CO2. Slices were then allowed to recover for at least one hour in ACSF at room
temperature (composition as above except for 1.3 mM MgSO4). Whole cell patch clamp
recordings were made from visually identified CA1 pyramidal neurons in the presence of
50μM picrotoxin at room temperature. The whole-cell solution contained (mM) 115
CsMeSO4, 20 CsCl2, 10 HEPES, 2.5 MgCl2, 4 NaATP, 0.4 NaGTP, 10 NaCreatine, and 0.6
EGTA (pH 7.2). Preparation of hippocampal and cortical slices from mice was similar
except that the ice cold ACSF for cutting was of the following composition (mM): 87 NaCl,
2.5 KCl, 0.5 CaCl2, 25 NaHCO3, 1.25 NaH2PO4, 25 glucose, 75 sucrose equilibrated with
95% O2 and 5% CO2, slices were then placed at 35 °C for 30 minutes, and then allowed to
recover for at least one hour in ACSF at room temperature.
EPSCs were evoked by electrical stimulation of two independent populations of Schaffer
collateral/commissural axons using two bipolar stimulating electrodes placed in stratum
radiatum of CA1 (0.1 Hz stimulation frequency). The stimulating electrodes were placed on
opposite sides from recorded cell from each other. For layer 2/3 pyramidal cell recordings
from the visual cortex, the stimulating electrode was placed in layer 4. NMDAR-mediated
EPSCs were obtained in the presence of NBQX (5μM) and picrotoxin (50μM) while cells
were voltage-clamped at +40 mV. Recordings in which the access resistance changed by
more than 10% were discarded and not included in our analysis. Recordings were performed
using a Multiclamp 700B patch-clamp amplifier (Axon Instruments, Foster City, CA);
signals were filtered at 4 kHz, digitized at 10 Hz and displayed and analyzed on-line using
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pClamp 9.2 (Axon Instruments). To drive the activity dependent switch in the subunit
composition of synaptic NMDA receptors from rat slices an LTP induction protocol was
employed, in which cells were voltage clamped at 0 mV while Schaffer collateral/
commissural axons were stimulated at 1Hz for 120 seconds, similar to that previously
described (Bellone and Nicoll, 2007). Cells were then voltage-clamped at −70 mV for 5
minutes following LTP induction. Following these 5 minutes, NMDA receptors EPSCs were
once again recorded at a holding potential of +40 mV. For mice, the induction protocol (100
Hz for 6 seconds) was employed in the absence of NBQX, and 20-30 minutes prior to
obtaining the whole cell configuration. For both rats and mice, the stimulating electrodes for
the test and control pathways were alternated to avoid differences in NMDA EPSC due to
proximal or distal synapses. Once cell per slice was used. NMDA EPSC decay was fit with a
double exponential function using OriginLab software (Northampton, MA) and decay
kinetics are expressed as a weighted decay time constant. All receptor antagonists were bath
applied at least 20 minutes prior to and during the induction protocol. For kinase inhibitors,
slices were preincubated with inhibitors for at least 1hour prior to the induction protocol.
Dark-rearing
For dark-rearing, male and female mice were used. Dark rearing commenced at P6 and mice
were raised in complete darkness until P17-P19. For light experience (LE) experiments,
dark-reared mice were exposed to 2.5 hours of light.
Statistics
Values are mean ± standard error of the mean (SEM). Statistical significance was tested
using a student’s t-test. For all experiments in which genotype was the experimental
variable, the ‘n’ was animal. All drugs, except for picrotoxin (Sigma Aldrich) were obtained
from Tocris Cookson.
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Figure 1. Activity-dependent switch from NR2B- to NR2A-containing NMDARs at hippocampal
CA1 pyramidal cell synapses
(A) Summary data of NMDA EPSC peak amplitude vs. time plot for two independent
pathways onto the same cell. In one pathway (test; red) the induction protocol was applied,
ifenprodil (5 μM) was bath-applied at the time indicated. (B) NMDA EPSCs from example
experiments for the test and control pathways taken at the times indicated in A. For this and
the other figures, NMDA EPSCs typically didn’t exhibit any change in peak amplitude after
the induction protocol and so are shown superimposed with no amplitude rescaling. (C)
NMDA EPSCs from an example experiment showing changes in the ifenprodil sensitivity in
the control and test paths after application of the induction protocol. (D) Summary graph
showing the average values for the weighted time constant (τw) in the control and test paths,
before and after the induction protocol (control path: pre-induction = 282 ± 23 ms, post-
induction = 277 ± 22 ms; test path: pre-induction = 285 ± 22 ms, post-induction = 218 ± 16
ms). (E) Summary graph for EPSC amplitude in the presence of ifenprodil expressed as
percentage of pre-ifenprodil amplitude (control path = 41 ± 4.1 %; test path = 76 ± 6.2 %). n
= 15 cells throughout; slices prepared from P5-7 rat; * indicates P < 0.05.
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Figure 2. mGluR5 and NMDAR activation are required for the activity-dependent switch in NR2
subunit composition
(A) Summary data of NMDA EPSC peak amplitude vs. time plot for two independent
pathways onto the same cell performed in the presence of bath-applied MTEP (10 μM). In
one pathway (test; red) the induction protocol was applied, ifenprodil (5 μM) was bath-
applied at the time indicated (n = 10). (B) NMDA EPSCs from example experiments for the
test and control pathways taken from the experiments in A. (C) NMDA EPSCs from an
example experiment showing changes in the ifenprodil sensitivity in the control and test
paths after application of the induction protocol. (D-F) As for A-C, but in the presence of
LY367385 (100 μM; n = 7). (G-I) As for A-C, but in the presence of D-AP5 (50 μM; n = 8).
(J) Summary graph showing the average values for the weighted time constant (τw) in the
control and test paths, before and after the induction protocol in the presence of the different
antagonists (control path: MTEP = 289 ± 8.2 ms, LY367385 = 298 ± 10.5 ms, not paired =
293 ± 14.3 ms, AP5 = 299 ± 11.2 ms, cycloheximide = 302 ± 13.5 ms; test path: MTEP =
282 ± 9.1 ms, LY367385 = 225 ± 11.8 ms, not paired = 276 ± 16.5 ms, AP5 = 302 ± 13.1
ms, cycloheximide = 228 ± 11.5 ms). (K) Summary graph for EPSC amplitude in the
presence of ifenprodil expressed as percentage of pre-ifenprodil amplitude in the presence of
the different antagonists (control path: MTEP = 45.2 ± 5.1 %, LY367385 = 42.1 ± 4.9 %,
not paired = 41.1 ± 4.8 %, AP5 = 44.4 ± 5.2 %, cycloheximide = 39.5 ± 4.8 %; test path:
MTEP = 52.3 ± 6.0 %, LY367385 = 72.1 ± 7.5 %, not paired = 51.5 ± 5.3 %, AP5 = 45.6 ±
4.5 %, cycloheximide = 64.5 ± 6.1 %).
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Figure 3. Signaling requirements for the activity-dependent switch in NR2 subunit composition
(A) Summary data of NMDA EPSC peak amplitude vs. time plot for two independent
pathways onto the same cell performed in the presence of bath-applied U73122 (5 μM). In
one pathway (test; red) the induction protocol was applied, ifenprodil (5 μM) was bath-
applied at the time indicated (n = 6). (B) NMDA EPSCs from example experiments for the
test and control pathways taken from the experiments in A. (C) NMDA EPSCs from an
example experiment showing changes in the ifenprodil sensitivity in the control and test
paths after application of the induction protocol. (D-F) As for A-C, but in the presence of
GFX109203 (1 μM; n = 8). (G-I) As for A-C, but in the presence of H89 (10 μM; n = 6) (J)
Summary graph showing the average values for the weighted time constant (τw) in the
control and test paths, before and after the induction protocol in the presence of a number of
different antagonists (control path: BAPTA = 280 ± 12 ms, thapsigargin = 298 ± 14 ms,
heparin = 278 ± 13 ms, 2APB = 302 ± 11 ms, U73122 = 293 ± 14 ms, GF109203X = 305 ±
10 ms, KN93 = 298 ± 11 ms, H89 = 311 ± 14 ms; test path: BAPTA = 271 ± 9 ms,
thapsigargin = 276 ± 16 ms, heparin = 265 ± 14 ms, 2APB = 289 ± 13 ms, U73122 = 286 ±
14 ms, GF109203X = 296 ± 13 ms, KN93 = 228 ± 14 ms, H89 = 241 ± 12 ms). (K)
Summary graph for EPSC amplitude in the presence of ifenprodil expressed as percentage of
pre-ifenprodil amplitude in the presence of the different antagonists (control path: BAPTA =
39.8 ± 6.2 %, thapsigargin = 42.1 ± 7.9 %, heparin = 38.6 ± 4.3 %, 2APB = 44.9 ± 6.7%,
U73122 = 43.9 ± 4.9 %, GF109203X = 43.2 ± 6.9 %, KN93 = 39.6 ± 6.4 %, H89 = 40.3 ±
5.5 %; test path: BAPTA = 40.1 ± 5.0 %, thapsigargin = 49.1 ± 5.7 %, heparin = 40.6 ± 5.6
%, 2APB = 41.6 ± 5.2 %, U73122 = 42.6 ± 3.8 %, GF109203X = 39.5 ± 8.0 %, KN93 =
68.0 ± 7.2 %, H89 = 71.1 ± 6.5 %). Horizontal lines indicate the average value in the control
path in absence of pharmacological agents; * indicates P < 0.05. Summary data expressed as
average ± sem. BAPTA, 10 mM, n = 6; thapsigargin, 5 μM, n = 7; heparin, 10 mg/mL, n =
6; 2APB, 100 μM, n = 7; GF109203X, 1 μM, n = 8; KN93, 10 μM, n = 7
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Figure 4. The activity-dependent switch in NR2 subunit composition induced in mouse
hippocampal slices
(A) Summary data of NMDA EPSC peak amplitude vs. time plot for two independent
pathways onto the same cell performed in mouse hippocampal slice (prepared from P5-7
mouse). In one pathway (test; red) the induction protocol (100 Hz tetanus for 6 s) was
applied prior to the start of whole-cell recording, ifenprodil (5 μM) was bath-applied at the
time indicated (n = 9). (B) NMDA EPSCs from example experiments for the test and control
pathways taken from the experiments in A. (C) NMDA EPSCs from an example experiment
showing changes in the ifenprodil sensitivity in the control and test paths after application of
the induction protocol. (D-F) As for A-C, but in the presence of MTEP (10 μM; n = 8). (G-I)
As for A-C, but in the presence of U73122 (5 μM; n = 7). (J) Summary graph showing the
average values for the weighted time constant (τw) in the control and test paths, before and
after the induction protocol in control (CT) and in the presence of the different antagonists
(control path: CT = 330 ± 20 ms, MTEP = 323 ± 17 ms, U73122 = 318 ± 23 ms, APV = 305
± 12 ms; test path: CT = 229 ± 14 ms, MTEP = 312 ± 15 ms, U73122 = 307 ± 18 ms, APV
= 300 ± 15 ms). (K) Summary graph for EPSC amplitude in the presence of ifenprodil
expressed as percentage of pre-ifenprodil amplitude (control path: CT = 41.7 ± 4.1 %,
MTEP = 44.9 ± 5.8 %, U73122 = 41.0 ± 3.5 %, APV = 39.5 ± 6.9 %; test path: CT = 66.4 ±
3.3 %, MTEP = 47.4 ± 4.6 %, U73122 = 43.4 ± 6.2 %, APV = 44.6 ± 5.8 %).
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Figure 5. Impaired activity-dependent NR2 subunit switch in the mGluR5 knock-out mice
(A) Summary data of NMDA EPSC peak amplitude vs. time plot for two independent
pathways onto the same cell performed in hippocampal slice from mGluR5 heterozygous
(het) mouse (P5-7). In one pathway (test; red) the induction protocol (100 Hz tetanus for 6 s)
was applied prior to the start of whole-cell recording, ifenprodil (5 μM) was bath-applied at
the time indicated (n = 16 mice). (B) NMDA EPSCs from example experiments for the test
and control pathways taken from the experiments in A. (C) NMDA EPSCs from an example
experiment showing changes in the ifenprodil sensitivity in the control and test paths after
application of the induction protocol. (D-F) As for A-C, but for mGluR5 knock-out (KO) (n
= 9 mice). (G) Summary graph showing the average values for the weighted time constant
(τw) in the control and test paths, before and after the induction protocol in mGluR5
heterozygous mice (het) and mGluR5 knock-out (KO) (control path: het = 358 ± 8 ms, KO =
361 ± 14 ms; test path: het = 284 ± 10 ms, KO = 338 ± 29 ms). (H) Summary graph for
EPSC amplitude in the presence of ifenprodil expressed as percentage of pre-ifenprodil
amplitude (control path: het = 41.0 ± 6.9 %, KO = 37.9 ± 2.6 %; test path: het = 68.2 ± 3.7
%, KO = 52.8 ± 6.5 %).
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Figure 6. Impaired developmental switch in NR2 subunit composition in hippocampus and
primary visual cortex ofmGluR5 knock-out mice
(A) Scaled NMDA EPSCs from hippocampal example experiments taken from wild type
(WT, black) and mGluR5 knock-out (KO, red). (B) NMDA EPSCs from hippocampal
example experiments taken showing ifenprodil sensitivity. (C) Summary graph showing the
average values for the weighted time constant (τw) in wild type (WT) and mGluR5 knock-
out (KO) at P15-18 (WT = 195 ± 8 ms, KO = 238 ± 10 ms). (D) Summary graph for EPSC
amplitude in the presence of ifenprodil expressed as percentage of pre-ifenprodil amplitude
for wild type (WT) and mGluR5 knock-out (KO) at P15-18 (WT = 75.4 ± 4.0 %, KO = 53.0
± 3.6 %). n = 8 mice (E-H) As for A-D, but for layer 4 inputs onto layer 2/3 pyramidal
neurons in primary visual cortex from P15-19 mice (decay kinetics: WT = 209 ± 9 ms, KO =
249 ± 13 ms; ifenprodil sensitivity: WT = 67.4 ± 5.3 %, KO = 48.7 ± 3.4 %). n = 8 mice. *p
< 0.05
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Figure 7. Impaired sensory-experience switch in the NR2 subunit composition in mGluR5
knock-out mice
(A) Scaled NMDA EPSCs from dark-reared wild type (WT, top) or mGluR5 knock out mice
(KO, bottom) without (black trace for WT and green trace for KO) or with (red traces) 2.5
hours light experience (LE). (B) Example traces for ifenprodil sensitivity in dark-reared wild
type mice (WT) without light experience (−LE, top) or with light experience (+LE, bottom).
(C) Example traces for ifenprodil sensitivity in dark-reared mGluR5 knock-out mice (KO)
without light experience (−LE, top) or with light experience (+LE, bottom). (D) Summary
graph showing the average values for the weighted time constant (τw) in wild type (WT) and
mGluR5 knock-out (KO) with or without LE (WT = 267 ± 18 ms, WT LE = 210 ± 9ms, KO
= 271 ± 10 ms, KO LE = 250 ± 8 ms). (E) Summary graph for NMDAR EPSC amplitude in
the presence of ifenprodil expressed as percentage of pre-ifenprodil amplitude for wild type
(WT) and mGluR5 knock-out (KO) with or without LE (WT = 49.4 ± 3.8 %, WT LE = 61.5
± 3.7 %, KO = 47.6 ± 3.9 %, KO LE = 53.5 ± 3.6 %). n = 10 animals, *p < 0.05
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Figure 8. Mechanism for the activity-dependent switch in NR2 subunit composition
Schematic of a dendritic spine showing the receptors and signaling pathways involved in the
activity-dependent NR2 subunit switch. The pharmacological agents used to block the
activity-dependent switch are also shown.
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